CHEBI:63825 - tamoxifen N-oxide

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name tamoxifen N-oxide
ChEBI ID CHEBI:63825
ChEBI ASCII Name tamoxifen N-oxide
Definition A tertiary amine oxide resulting from the formal oxidation of the amino group of tamoxifen.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
more structures >>
Formula C26H29NO2
Net Charge 0
Average Mass 387.515
Monoisotopic Mass 387.21983
InChI InChI=1S/C26H29NO2/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)29-20-19-27(2,3)28/h5-18H,4,19-20H2,1-3H3/b26-25-
InChIKey YAASNACECBQAFW-QPLCGJKRSA-N
SMILES C=1(C=CC=CC1)/C(=C(/C=2C=CC=CC2)\C=3C=CC(=CC3)OCC[N+]([O-])(C)C)/CC
Roles Classification
Biological Role(s): metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
Application(s): anti-estrogen
A drug which acts to reduce estrogenic activity in the body, either by reducing the amount of estrogen or by reducing the activity of whatever estrogen is present.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing tamoxifen N-oxide (CHEBI:63825) has functional parent tamoxifen (CHEBI:41774)
tamoxifen N-oxide (CHEBI:63825) has parent hydride stilbene (CHEBI:26775)
tamoxifen N-oxide (CHEBI:63825) has role anti-estrogen (CHEBI:50751)
tamoxifen N-oxide (CHEBI:63825) has role metabolite (CHEBI:25212)
tamoxifen N-oxide (CHEBI:63825) is a aromatic ether (CHEBI:35618)
tamoxifen N-oxide (CHEBI:63825) is a tertiary amine oxide (CHEBI:134363)
IUPAC Name
(2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)dimethylamine oxide
Manual Xref Database
C16545 KEGG COMPOUND
View more database links
Registry Numbers Types Sources
75504-34-6 CAS Registry Number ChemIDplus
8504138 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
11545399 PubMed citation Europe PMC
19166339 PubMed citation Europe PMC
7138577 PubMed citation Europe PMC
Last Modified
01 February 2017